RSS-Feed abonnieren

DOI: 10.1055/s-0045-1811244
Anterior Cerebral Artery Dissection Leading to Severe Subarachnoid Hemorrhage in a Post-Pandemic COVID-19 Patient: A Case Report and a Call for Continued Vigilance
Authors
Funding None.

Abstract
Coronavirus disease 2019 (COVID-19) can lead to systemic vascular complications, such as endothelial damage and hypercoagulability. Although COVID-19-associated nonaneurysmal subarachnoid hemorrhage (SAH) has been reported, cases involving anterior cerebral artery (ACA) dissection, particularly in the A1 segment, are extremely rare. A 57-year-old man with a recent COVID-19 infection was brought to the emergency department in an unconscious state. Imaging revealed diffuse SAH, and computed tomography angiography identified dissection of the right ACA A1 segment. Urgent surgical intervention with clipping of the dissected segment was performed. Although the patient initially stabilized postoperatively, he subsequently developed severe cerebral infarction, leading to progressive neurological decline. Despite intensive care, the patient succumbed to these complications 10 days after the initial presentation. Although the overall threat of COVID-19 has diminished, vigilance is still required because its vascular complications remain potentially fatal. COVID-19-associated SAH may have a higher mortality rate due to mechanisms distinct from saccular aneurysm rupture, such as arterial dissection and systemic effects. Dissecting an aneurysm of the A1 segment of the ACA is an extremely rare but serious complication, and its management remains challenging. Further studies are required to understand and mitigate COVID-19-related vascular pathologies.
Authors' Contributions
S.H. drafted this case report. K.Y. made the design of this case report and revised the report. M.S., T.T., and H.A. treated this patient and checked this report. A.M. and E.I. revised the report and advised the manuscript. All authors reviewed the final version of the case report.
Ethical Approval
This case report complies with the Declaration of Helsinki.
Publikationsverlauf
Artikel online veröffentlicht:
08. September 2025
© 2025. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Elrobaa IH, New KJ. COVID-19: pulmonary and extra pulmonary manifestations. Front Public Health 2021; 9: 711616
- 2 Foster CH, Vargas AJ, Wells E, Keating RF, Magge SN. Cerebral vasculopathy and strokes in a child with COVID-19 antibodies: illustrative case. J Neurosurg Case Lessons 2021; 2 (03) CASE21160
- 3 Ellens NR, Silberstein HJ. Spontaneous intracranial hemorrhage presenting in a patient with vitamin K deficiency and COVID-19: illustrative case. J Neurosurg Case Lessons 2021; 1 (11) CASE20163
- 4 Ravindra VM, Grandhi R, Delic A. et al. Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States. PLoS One 2021; 16 (04) e0248728
- 5 Kajita M, Yanaka K, Akimoto K, Aiyama H, Ishii K, Ishikawa E. Nonaneurysmal subarachnoid hemorrhage associated with COVID-19 infection: a case report. Surg Neurol Int 2022; 13: 524
- 6 Al-Mufti F, Becker C, Kamal H. et al. Acute cerebrovascular disorders and vasculopathies associated with significant mortality in SARS-CoV-2 patients admitted to the intensive care unit in the New York epicenter. J Stroke Cerebrovasc Dis 2021; 30 (02) 105429
- 7 Hoelscher C, Sweid A, Ghosh R. et al. Cerebral deep venous thrombosis and COVID-19: case report. J Neurosurg 2020; 135 (01) 17-20
- 8 Inagawa T. Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg 2016; 85: 56-76
- 9 Ioannidis JPA. The end of the COVID-19 pandemic. Eur J Clin Invest 2022; 52 (06) e13782
- 10 Romero-Severson EO, Hengartner N, Meadors G, Ke R. Change in global transmission rates of COVID-19 through May 6 2020. PLoS One 2020; 15 (08) e0236776
- 11 Bourgonje AR, Abdulle AE, Timens W. et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020; 251 (03) 228-248
- 12 Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc 2020; 95 (06) 1222-1230
- 13 Lim MJR, Yeo J, Fong KY. et al. Characteristics of subarachnoid hemorrhage associated with COVID-19 infection: a systematic review and descriptive analysis. J Stroke Cerebrovasc Dis 2023; 32 (02) 106904
- 14 Wajima D, Shimozato R, Takeshita T, Nagamine T. Ruptured cerebral aneurysms and dissecting aneurysms in patients with COVID-19: a case series and literature review. Indian J Neurosurg 2024; 13 (02) 156-162
- 15 van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124 (Pt 2): 249-278
- 16 Mizutani T, Kojima H, Asamoto S, Miki Y. Pathological mechanism and three-dimensional structure of cerebral dissecting aneurysms. J Neurosurg 2001; 94 (05) 712-717
- 17 Elhadi AM, Zabramski JM, Almefty KK. et al. Spontaneous subarachnoid hemorrhage of unknown origin: hospital course and long-term clinical and angiographic follow-up. J Neurosurg 2015; 122 (03) 663-670